Surgery

Solar stent surgery

Solaris develops its flagship SX vascular stent graft as a minimally invasive treatment for these conditions. It employs an advanced electrospinning PTFE impermeable membrane that prevents tissue ingrowth, maximizes patency, and reduces restenosis. Solaris SX is currently not approved in the US and is in the process of. . The SOLARIS is a flexible self-expanding endograft, comprised of a thin multi-direction durable electrospinning PTFE membrane encapsulating a Nitinol stent structure. The device has been engineered to effectively cover and instantaneously seal off diseased tissue with a higher multidirectional. . With a proven stent platform and innovative drug-eluting technology, we are revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD). To deliver groundbreaking, evidence-based solutions that extend the patency of dialysis access grafts, fistulas and peripheral. . Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for Solaris DE — the first of its kind, drug-eluting covered stent that will address the remaining unmet need in covered stents: edge stenosis. Whether you have been diagnosed with coronary artery disease (CAD) or suffered a myocardial infarction (MI), understanding the intricacies of this procedure is vital. The. . Coronary angioplasty (AN-jee-o-plas-tee) is a procedure to open clogged blood vessels of the heart.

[PDF Version]